The global digital pathology market to reach USD 1371M by 2026

The global digital pathology market is projected to reach USD 1,371 million by 2026 from USD 736 million in 2021, at a CAGR of 13.2% during the forecast period. The growth in the digital pathology market is mainly driven by factors such as the increasing adoption of digital pathology to enhance lab efficiency, rising incidence of cancer, and growing applications of digital pathology in drug development and companion diagnostics.

The scanners segment accounted for the largest share of the digital pathology market in 2020.
Based on products, the digital pathology market has been segmented into scanners, software, and storage systems. The large share of the scanners segment can be attributed to the high price of scanners and the increasing adoption of digital pathology solutions.

The human pathology segment accounted for the largest share of the digital pathology market in 2020
Based on type, the global digital pathology market is segmented into human pathology and veterinary pathology.The human pathology segment accounted for the largest share of the digital pathology market in 2020.

This is due to the increasing number of cancer research activities and growing collaborations among research institutes, universities, and pathology laboratories.

The drug discovery, segment accounted for the largest share of the digital pathology market in 2020.
Based on application, the digital pathology market is segmented into drug discovery, disease diagnosis, and training & education.The drug discovery segment accounted for the largest share of the digital pathology market in 2020.

Growth in R&D expenditure fueled by the need for numerous preclinical and clinical studies performed during the drug discovery and development process is a major factor responsible for market growth.

The pharmaceutical & biotechnology companies, segment accounted for the largest share of the digital pathology market in 2020.
Based on end users, the global digital pathology market is segmented into pharmaceutical & biotechnology companies, hospitals & reference laboratories, and academic & research institutes.The pharmaceutical & biotechnology companies segment accounted for the largest share of the digital pathology market in 2020.

The large share of this segment can be attributed to the increasing use of digital pathology for drug discovery studies and drug toxicology testing. Biotechnology companies also use digital pathology for biobanking, biopharmaceutical studies, molecular assays, and the development of individualized medicine.

The market in North America is projected to witness the highest growth rate during the forecast period (2021–2026).
North America accounted for the largest share of the digital pathology market in 2020. The increasing prevalence of cancer, rising demand for quality diagnostics, the introduction of favorable reimbursement policies, and the implementation of favorable initiatives by the governments in the US and Canada are major factors driving the growth of the digital pathology market in North America.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type (Supply-side): Tier 1: 29%, Tier 2: 37%, and Tier 3: 34%
• By Company Type (Demand-side): Tier 1: 55%, Tier 2: 35%, and Tier 3: 10%
• By Designation: C-level: 35%, Director-level: 25%, and Others: 40%
• By Region: North America: 35%, Europe: 32%, Asia-Pacific: 22%, and RoW:11%

The major players in the digital pathology market include Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), Hamamatsu Photonics (Japan), F. Hoffmann-La Roche Ltd. (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN, Inc. (US), Huron digital pathology (Canada), Visiopharm A/S (Denmark), Aiforia Technologies Oy (Finland), Akoya Biosciences (US), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (US), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD. (China), Inspirata, Inc. (US), PathAI (US), Proscia Inc. (US), Kanteron Systems (Spain), Mikroscan Technologies (US), Motic (US), and Paige (US).

Research Coverage:
The report analyzes the digital pathology market and aims at estimating the market size and future growth potential of this market based on various segments such as product, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies. ReportLinker